Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Nuvation Bio Inc (NYSE: NUVB) closed at $2.80 down -5.08% from its previous closing price of $2.95. In other words, the price has decreased by -$5.08 from its previous closing price. On the day, 2.39 million shares were traded. NUVB stock price reached its highest trading level at $3.0 during the session, while it also had its lowest trading level at $2.78.
Ratios:
For a deeper understanding of Nuvation Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.49 and its Current Ratio is at 11.49. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 27, 2024, Upgraded its rating to Buy and sets its target price to $10 from $1.40 previously.
On March 26, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
Jefferies Downgraded its Buy to Hold on January 06, 2023, whereas the target price for the stock was revised from $5 to $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 25 ’24 when Cui Xiangmin bought 277,895 shares for $2.97 per share. The transaction valued at 825,348 led to the insider holds 2,453,131 shares of the business.
Cui Xiangmin bought 336,874 shares of NUVB for $1,003,885 on Jun 24 ’24. The Director now owns 2,175,236 shares after completing the transaction at $2.98 per share. On Jun 20 ’24, another insider, Cui Xiangmin, who serves as the Director of the company, bought 87,715 shares for $2.99 each. As a result, the insider paid 262,268 and bolstered with 1,762,951 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUVB now has a Market Capitalization of 937384000 and an Enterprise Value of 410337376. For the stock, the TTM Price-to-Sale (P/S) ratio is 484.65 while its Price-to-Book (P/B) ratio in mrq is 2.71. Its current Enterprise Value per Revenue stands at 285.949 whereas that against EBITDA is -0.764.
Stock Price History:
Over the past 52 weeks, NUVB has reached a high of $4.16, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -10.15%, while the 200-Day Moving Average is calculated to be 9.03%.
Shares Statistics:
For the past three months, NUVB has traded an average of 1.67M shares per day and 1684950 over the past ten days. A total of 218.05M shares are outstanding, with a floating share count of 141.57M. Insiders hold about 43.20% of the company’s shares, while institutions hold 52.59% stake in the company. Shares short for NUVB as of 1724976000 were 17962142 with a Short Ratio of 10.73, compared to 1722384000 on 15735800. Therefore, it implies a Short% of Shares Outstanding of 17962142 and a Short% of Float of 11.78.
